Indegene

Indegene EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Indegene (INDGN.NS) as of Oct 22, 2026 is 15.14. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 22.21 — a change of -31.86% (lower).

EV/OCF

15.14

YoY

-31.86%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Indegene is 2026 15.14 . EV/OCF (Enterprise Value to Operating Cash Flow) of Indegene was 2025 22.21 . It decreases by -31.86% lower compared to the previous year.

The Indegene EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2020
524.76 INR
Jan 1, 2021
65.67 INR
Jan 1, 2022
36.42 INR
Jan 1, 2023
85.78 INR
Jan 1, 2024
21.44 INR
Jan 1, 2025
22.21 INR
Jan 1, 2026
15.14 INR
The Indegene EV/OCF history
YEAREV/OCFYoY
15.14-31.86%
22.21+3.62%
21.44-75.01%
85.78+135.53%
36.42-44.54%
65.67-87.49%
524.76—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indegene Stock analysis

What does Indegene do? Indegene Ltd generates revenue by providing digital-led commercialization services to life sciences companies, including biopharmaceutical, emerging biotech, and medical devices firms. The company assists these clients with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and the sales and marketing of their products. This comprehensive support structure allows Indegene to serve as a key partner in the end-to-end commercialization process for its diverse client base within the life sciences sector. The company monetizes its offerings through specialized solution segments such as Omnichannel Activation, which helps life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Additionally, Enterprise Commercial Solutions primarily involves assisting life sciences companies with their digital marketing operations, further expanding the company's service portfolio and revenue streams. Revenue is also derived from Enterprise Medical Solutions, where Indegene establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The company rounds out its business model by offering enterprise clinical solutions and consultancy services, ensuring a holistic service delivery model that addresses various operational needs of its customers in the life sciences industry. Indegene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indegene stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Indegene is 15.14 in 2026.

EV/OCF (Enterprise Value to Operating Cash Flow) of Indegene changed from 22.21 to 15.14, representing a -31.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Indegene since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Indegene with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Indegene

All Key Metrics — Indegene